This MedLibrary.org supplementary page on MBDB is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
 |
|
|
MBDB
|
|
| Systematic (IUPAC) name | |
| 1-(1,3-Benzodioxol-5-yl)-N-methylbutan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H17NO2 |
| Mol. mass | 207.27 g/mol |
| SMILES | & |
| Physical data | |
| Melt. point | 156 °C (313 °F) |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
MBDB, or 3,4-methylenedioxy-alpha-ethyl-N-methylphenethylamine, is a lesser-known hallucinogenic phenethylamine. It is also known as "EDEN" or "Methyl-J." It is the alpha-ethyl analog of MDMA (Esctasy). It was first synthesized by David E. Nicholscitation needed, a leading pharmacologist and medicinal chemist, and later tested by Alexander Shulgin and written up in his book, PiHKAL (Phenethylamines i Have Known And Loved). MBDB's dosage, according to PiHKAL, is 180-210mg; the proper dosage relative to body mass seems unknown. Its duration is 4-6 hours, with noticeable after-effects lasting for 1-3 hours.
MBDB was initially developed as a non-psychedelic empathogen. It has no effect on the dopamine system which makes it less stimulating and less toxic than MDMA. MBDB causes many mild, MDMA-like effects, such as lowering of social barriers and inhibitions, a pronounced sense of empathy and compassion, and mild happiness, euphoria, and enhanced emotions are all present. However, MBDB's effects are much less profound then those of MDMA. MBDB's effects tend to produce less euphoria, less psychedelia, and have less stimulative properties than MDMA does. Many users declare that MBDB is a "watered-down" version of MDMA as MBDB loses action much more quickly, due to the milder effects, lack of a "rush," and its sedative effects. Despite these features which make MBDB less desirable as a 'recreational' drug, it has been suggested that the drug may have greater therapeutic potential than MDMA because of its decreased toxicity and lengthened duration.
Contraindications
- MAOIs, specifically MAO-A inhibitors and non-selective MAOIs may precipitate serotonin syndrome when combined with MBDB.
- Driving and operating heavy machinery may be especially hazardous as MBDB has a fairly pronounced sedative action.
External links
|
|||||
|
|||||
|
|||||
Wikipedia content modification information:
- This page was last modified on 11 October 2008, at 21:19.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "MBDB".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.